Unknown OBSERVATIONAL NCT02448901

Influence of Edoxaban on Coagulability and Thrombin Generation: An in Vitro Study Focusing on Thrombelastography

Sponsor: Daiichi Sankyo

Interventions Edoxaban

Updated 9 times since 2017 Last updated: May 15, 2015 Started: Apr 30, 2015 Primary completion: Feb 29, 2016 Completion: Mar 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Heart Failure, this trial is ongoing. The trial is conducted by Daiichi Sankyo and has accumulated 9 data snapshots since 2015. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Mar 2024 — Jul 2024 [monthly]

Unknown Status
Jan 2021 — Mar 2024 [monthly]

Unknown Status
Jun 2018 — Jan 2021 [monthly]

Unknown Status

▶ Show 4 earlier versions

Apr 2018 — Jun 2018 [monthly]

Unknown Status

Phase: NA → None
Sep 2017 — Apr 2018 [monthly]

Unknown Status NA
Jun 2017 — Sep 2017 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Jan 2017 — Jun 2017 [monthly]

Recruiting NA

First recorded

Apr 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Daiichi Sankyo
LifeBridge Health

Data source: LifeBridge Health

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Baltimore, United States